N. Koseki

Assessment of Ethnic Differences in the Pharmacokinetics and Pharmacodynamics of Valsartan

G. Sunkara, M. Ligueros-Saylan, C. Yeh, 2010 .

Development and validation for high selective quantitative determination of metformin in human plasma by cation exchanging with normal-phase LC/MS/MS.

H. Kawashita, N. Koseki, Y. Nagae, 2005, Journal of pharmaceutical and biomedical analysis.

Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry.

Makoto Tanaka, R. Kawai, H. Kawashita, 2007, Journal of pharmaceutical and biomedical analysis.

13C NMR assignments of brassinosteroids by two‐dimensional techniques

T. Ando, H. Abé, N. Koseki, 1993 .

Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.

I. Kanazawa, F. Shibasaki, J. Goto, 2000, Human molecular genetics.

Insecticidal activity of new fluorinated pyrethroids and their stability toward chemical oxidation and photoreaction

T. Ando, N. Koseki, T. Ishiwatari, 1994 .

Simultaneous quantitative determination of cyclosporine A and its three main metabolites (AM1, AM4N and AM9) in human blood by liquid chromatography/mass spectrometry using a rapid sample processing method.

N. Koseki, Y. Nagae, N. Masuda, 2006, Rapid communications in mass spectrometry : RCM.

Highlights of the 12th Japan Bioanalysis Forum Symposium.

Yoshiaki Ohtsu, N. Koseki, Makoto Takahashi, 2021, Bioanalysis.